CuraTeQ Biologics
Souvik Nayak is a Research Associate in Advanced Analytical Sciences at CuraTeQ Biologics since July 2024, following experience as Scientist - III in the Research & Development Department at Biocon Biologics from October 2021 to July 2024, focusing on biosimilars and biologics analysis using HPLC and other bioinstruments. Prior to this, Souvik was a Postgraduate Researcher at Jain (Deemed-to-be University) where a dissertation on "Protease inhibitors from Microbial isolates and evaluation of their anticancer potential” was completed. Additional experience includes a Research Internship at the Central Silk Board under Dr. K and multiple research projects during undergraduate studies at Maulana Abul Kalam Azad University of Technology, where significant work was conducted in biodiversity and major dissertation research. Souvik holds a Master of Science in Biotechnology from Jain (Deemed-to-be University) and a Bachelor of Science in Biotechnology from Maulana Abul Kalam Azad University of Technology.
This person is not in the org chart
This person is not in any teams
CuraTeQ Biologics
CuraTeQ Biologics (a wholly owned subsidiary of Aurobindo Pharma Ltd.) is a biopharmaceutical company based out of Hyderabad, India. Our vision is to improve the wellbeing of patients suffering from debilitating illnesses by providing them access to high quality and cost-effective biosimilars. CuraTeQ has a development pipeline of 14 biosimilars, of which, three products have been filed with EMA, one product has been filed with MHRA, and four more products are in global phase 3 clinical trials. Our Mission: ● Deliver exceptional value to stakeholders and better health outcomes to patients by becoming a leading global biosimilars developer by 2030. ● Build deep capabilities in development and manufacturing to deliver quality and cost-effective biosimilars for patients across the globe. ● Create a sustainable and broad portfolio of biosimilars with a focus on oncology and immunology therapies.